Malhotra Gurveen, Ramreddy Nitya, Chua Serafin, Iliescu Mira, Kaur Tanjeev
University of Illinois at Chicago, Chicago, IL 60612, USA.
Internal Medicine, Mount Sinai Hospital, Chicago, IL 60608, USA.
Case Rep Crit Care. 2016;2016:7379829. doi: 10.1155/2016/7379829. Epub 2016 Jun 28.
Antisynthetase (AS) syndrome is a major subgroup of inflammatory myopathies seen in a minority of patients with dermatomyositis and polymyositis. Although it is usually associated with elevated creatine phosphokinase level, some patients may have amyopathic dermatomyositis (ADM) like presentation with predominant skin involvement. Interstitial lung disease (ILD) is the main pulmonary manifestation and may be severe thereby determining the prognosis. It may rarely present with a very aggressive course resulting in acute respiratory distress syndrome (ARDS). We report a case of a 43-year-old male who presented with nonresolving pneumonia who was eventually diagnosed to have ADM through a skin biopsy without any muscle weakness. ADM may be associated with rapidly progressive course of interstitial lung disease (ADM-ILD) which is associated with high mortality. Differentiation between ADM-ILD and AS syndrome may be difficult in the absence of positive serology and clinical presentation may help in clinching the diagnosis.
抗合成酶(AS)综合征是炎性肌病的一个主要亚组,见于少数皮肌炎和多肌炎患者。虽然它通常与肌酸磷酸激酶水平升高有关,但一些患者可能有以皮肤受累为主的无肌病性皮肌炎(ADM)样表现。间质性肺疾病(ILD)是主要的肺部表现,可能很严重,从而决定预后。它很少以非常侵袭性的病程出现,导致急性呼吸窘迫综合征(ARDS)。我们报告一例43岁男性患者,表现为不缓解的肺炎,最终通过皮肤活检诊断为ADM,无任何肌肉无力症状。ADM可能与间质性肺疾病的快速进展病程(ADM-ILD)相关,后者与高死亡率相关。在没有阳性血清学结果的情况下,区分ADM-ILD和AS综合征可能很困难,临床表现可能有助于确诊。